⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7706452 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL8800650 | 0.98 | — | — | |
| SCHEMBL7951217 | 0.86 | — | — | |
| SCHEMBL7947695 | 0.86 | — | — | |
| SCHEMBL1297748 | 0.86 | — | — | |
| SCHEMBL10744452 | 0.82 | CHRNB2 (0.41) | — | |
| Bromide SCHEMBL8650212 | 0.82 | CHRNB2 (0.41) | — | |
| Hydrochloric Acid SCHEMBL232525 | 0.82 | CHRNB2 (0.41) | — | |
| SCHEMBL8417799 | 0.82 | CHRNB2 (0.41) | — | |
| Hydrochloric Acid SCHEMBL7391981 | 0.80 | CHRNB2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1229905-A2 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1- AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-[3(3-METHOXYPHENYL)-2-PROPYNYL]OXIME | 3M Innovative Properties Company (US) | 2002-08-14 | — | — | EP | claimed |
| WO-2001030316-A2 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-03 | — | — | WO | claimed |
| US-6121459-A | Single pot process for producing (Z)-azabicyclo oxime ethers | WARNER-LAMBERT COMPANY (US) | 2000-09-19 | — | — | US | claimed |
| US-6121306-A | Method of making (1S, 4R)-1-azabicyclo[2.2.1]heptan-3-one and (1R, 4S), 1-azabicyclo[2.2.1]heptan-3-one | WARNER-LAMBERT COMPANY (US) | 2000-09-19 | — | — | US | claimed |
| EP-0839148-B1 | (R)-(Z)-1-AZABICYCLO 2.2.1]HEPTAN-3-ONE,O- 3-(3-METHOXYPHENYL)-2-PROPYNYL]OXIME MALEATE AS A PHARMACEUTICAL AGENT | WARNER LAMBERT CO (US) | 1999-12-22 | — | — | EP | claimed |
| US-20170129915-A1 | THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH NERVE AXON DYSFUNCTION, INCLUDING THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE | RESILIO COMPANY LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| US-9453000-B2 | Polycyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-09-27 | — | — | US | disclosed |
| US-20150126464-A1 | THERAPEUTIC DRUG AND THERAPEUTIC METHOD FOR NEUROLOGICAL DISEASES INCLUDING ALZHEIMER'S DISEASE ASSOCIATED WITH 1,25D3-MARRS | RESILIO COMPANY LIMITED (JP) | 2015-05-07 | — | — | US | disclosed |
| EP-2559693-B1 | Polycyclic compound | EISAI R&D MAN CO LTD (JP) | 2014-11-26 | — | — | EP | disclosed |
| EP-2493893-B1 | AZABICYCLO[2.2.1]HEPTANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | BRISTOL MYERS SQUIBB CO (US) | 2014-01-15 | — | — | EP | disclosed |
| EP-2615090-A1 | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors | Eisai R&D Management Co., Ltd. (JP) | 2013-07-17 | — | — | EP | disclosed |
| EP-2401276-B1 | NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS BETA AMYLOID PRODUCTION INHIBITORS | EISAI R&D MAN CO LTD (JP) | 2013-06-05 | — | — | EP | disclosed |
| WO-2001030316-A3 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME | 3M INNOVATIVE PROPERTIES CO (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001030316-A2 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-03 | — | — | WO | disclosed |
| WO-2001030316-A2 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6121459-A | Single pot process for producing (Z)-azabicyclo oxime ethers | WARNER-LAMBERT COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6121306-A | Method of making (1S, 4R)-1-azabicyclo[2.2.1]heptan-3-one and (1R, 4S), 1-azabicyclo[2.2.1]heptan-3-one | WARNER-LAMBERT COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| EP-0764165-A1 | PREPARATION OF STEREOCHEMICALLY PURE OXIMES WITH MUSCARINIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995034562-A1 | PREPARATION OF STEREOCHEMICALLY PURE OXIMES WITH MUSCARINIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1995-12-21 | — | — | WO | disclosed |
| US-5346911-A | Analgesics, cognition activators, treatment of alzheimer*s s disease | WARNER-LAMBERT COMPANY (US) | 1994-09-13 | — | — | US | disclosed |